Modulation of MHC class I/II antigens and cell surface glycoconjugates by the fusion IL6/IL2 transduction.

被引：0
|
作者：
Yu, HD [1 ]
Tang, PH [1 ]
Zhao, CH [1 ]
Huang, Y [1 ]
Liu, YL [1 ]
Mao, N [1 ]
机构：
[1] SINOCHEM INST BIOTECHNOL,INST BASIC MED SCI,BEIJING,PEOPLES R CHINA
来源：
EXPERIMENTAL HEMATOLOGY | 1996年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：386 / 386
页数：1
相关论文
共 50 条
  • [21] TYPING OF HLA CLASS-II AND CLASS-I ANTIGENS USING PHA-ACTIVATED, IL-2-PROPAGATED LYMPHOCYTES-T
    LESHEM, B
    COHEN, I
    SHERMAN, L
    BRAUTBAR, C
    KEDAR, E
    JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 111 (01) : 131 - 135
  • [22] Involvement of MHC class I molecule and ICAM-1 in the enhancement of adhesion and cytotoxic susceptibility to immune effector cells of tumor cells transfected with the interleukin (IL)-2, IL-4 or IL-6 gene
    Cao, XT
    Chen, GY
    He, L
    Zhang, WP
    Yu, YZ
    Wang, JL
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1997, 123 (11-12) : 602 - 608
  • [23] CLL cell proliferation and IL-6 production are regulated by CD160-MHC class I interactions offering new therapeutic targets
    Giustiniani, Jerome
    Wiseman, Catherine
    Farren, Timothy
    Gribben, John G.
    Agrawal, Samir G.
    BLOOD, 2007, 110 (11) : 342A - 342A
  • [24] EXPRESSION OF MHC CLASS-II AND TAC ANTIGENS ON IL2-ACTIVATED HUMAN T-CELL CLONES THAT CAN STIMULATE IN MLR, AMLR, PLT AND CAN PRESENT ANTIGEN
    TRIEBEL, F
    DEROQUEFEUIL, S
    BLANC, C
    CHARRON, DJ
    DEBRE, P
    HUMAN IMMUNOLOGY, 1986, 15 (03) : 302 - 315
  • [25] Involvement of IL-2Rβ+ T cells in graft-versus-host disease of the liver and intestine across mutant MHC class I or class II barrier
    Hasegawa, K
    Seki, S
    Yamagiwa, S
    Sato, K
    Sugahara, S
    Hiraide, H
    Asakura, H
    Abo, T
    BIOMEDICAL RESEARCH-TOKYO, 1998, 19 (01): : 9 - 19
  • [26] INDUCTION OF CLASS-I AND CLASS-II MHC ANTIGEN EXPRESSION ON MURINE BONE MARROW-DERIVED MACROPHAGES BY IL-4 (B-CELL STIMULATORY FACTOR-I)
    STUART, PM
    ZLOTNIK, A
    WOODWARD, JG
    JOURNAL OF IMMUNOLOGY, 1988, 140 (05): : 1542 - 1547
  • [27] FREQUENCY-ANALYSIS OF CLASS-I MHC-REACTIVE LYT-2+ AND CLASS-II MHC-REACTIVE L3T4+ IL 2-SECRETING LYMPHOCYTES-T
    HEEG, K
    STEEG, C
    SCHMITT, J
    WAGNER, H
    JOURNAL OF IMMUNOLOGY, 1987, 138 (12): : 4121 - 4127
  • [28] Allogeneic genetically modified tumor cell vaccine (LNCaP IL2/IFNγ) in patients with hormone-refractory prostate cancer a phase I/II clinical trial
    不详
    IMMUNOBIOLOGY, 2005, 210 (6-8) : 458 - 459
  • [29] MODULATION BY GLYCYRRHIZIN OF THE CELL-SURFACE EXPRESSION OF H-2 CLASS-I ANTIGENS ON MURINE TUMOR-CELL LINES AND NORMAL-CELL POPULATIONS
    ZHANG, YH
    YOSHIDA, T
    ISOBE, K
    RAHMAN, SMJ
    NAGASE, F
    DING, L
    NAKASHIMA, I
    IMMUNOLOGY, 1990, 70 (03) : 405 - 410
  • [30] Critical role of IL-4 for delayed rejection of major histocompatibility complex (MHC) class I and II incompatible skin grafts after Th2 vaccination.
    Ogilvie, ALJ
    Biedermann, T
    Sander, CA
    Schiller, PT
    Rocken, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) : 415 - 415
12345